Navigation Links
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
Date:11/10/2008

0.29) ($0.74) ($1.54)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average

number of

common shares

outstanding 49,954,777 47,495,376 49,312,636 42,360,279

-------------------------------------------------------------------------

-------------------------------------------------------------------------

At At

September 30 December 31

Consolidated Balance Sheets 2008 2007

-------------------------------------------------------------------------

-------------------------------------------------------------------------

(unaudited) (audited)

Cash, cash equivalents and marketable

securities $20,595 $58,672

Other current assets 3,203 3,933

-------------------------------------------------------------------------

Total current assets 23,798 62,605

Capital assets and patents 9,743 9,996

Other long-term assets 10,229 5,830

-------------------------------------------------------------------------

Total assets $43,770 $78,431

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Current liabilities $18,955 $21,240

Long-term deferred gain and liabilities 53,327 52,602

Non-controll
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
2. BELLUS Health provides update on activities
3. BELLUS Health announces closing of Innodia acquisition
4. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
5. BELLUS HEALTH reports results for first quarter of fiscal 2008
6. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
7. Healthcare Realty Trust Announces Third Quarter Results
8. World Publics See Government as Responsible for Ensuring Basic Healthcare, Food, and Education Needs
9. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
10. Major Mental Health Associations Join to Support Give an Hour
11. Wyeth to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 1MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 2MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 3MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 4MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 5MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 6Astellas Hires New Vice President of Compliance 47666 1Astellas Hires New Vice President of Compliance 47666 2Scientists use bed bugs own chemistry against them 47664 1Scientists use bed bugs own chemistry against them 47664 2Scientists use bed bugs own chemistry against them 47664 3Scientists use bed bugs own chemistry against them 47664 4